[ad_1]
Nanogen Company plans a two-shot dose of the Covid-19 Nanocovax vaccine priced at 240,000 VND, and if tested safely, it will be vaccinated in May 2021.
Mr. Do Minh Si, Director of Research and Development at Nanogen, on the morning of December 10, said that this price is calculated by company leaders and project members, including production costs and clinical trials.
On December 8, company representatives said they were considering the sale price of the Nanocovax vaccine, which is expected not to exceed 500,000 VND per dose of two injections, which can be covered by insurance.
Nanogen Company plans to produce 50-70 million doses of Nanocovax per year, first to meet domestic demand and then to export.
“Our production scale is approximately 10 to 20 million doses per year, so Nanogen is increasing the production scale,” Si said.
Nanogen Company employee holding a sample of the Nanocovax vaccine, at the District 9 laboratory, Ho Chi Minh City, on December 8. Image: Quynh Tran.
Nanocovax was ordered by the Ministry of Science and Technology, the research and development process took only 6 months. Nanogen cooperated with the Military Medical Academy to investigate, with the support of the Ministry of Health, the Ministry of Science and Technology, testing institutes …, so the huge workload is completed quickly, the time is greatly shortened. times.
This is the first Covid-19 vaccine in Vietnam to conduct a human clinical trial. Phase one, launched on December 10, tested 60 volunteers, phase two around 400 people and went straight to phase three. The number of participants in the third stage is unknown. If the testing process is favorable, the vaccine is expected to be vaccinated around May 2021.
The Nanocovax vaccine uses recombinant protein technology, that is, sequencing a segment of the spiny protein S in nCoV, integrating it into a line of cultured animal cells. Cells divide, grow, and make proteins. The protein is then separated, cleaned, and made into a semi-finished product. It is formulated with other excipients to form vaccines.
Mr. Si said that recombinant protein technology has been applied by Nanogen for approximately 10 years in many product lines.
“With the Covid-19 vaccine, the maximum dose is only 75 mcg, which makes it safe,” he said.
Ho Nhan, Managing Director of Nanogen emphasized: “If we don’t have an early vaccine, it will take another half of 2021, even 2022, because the epidemic will just break out and then control. Human life loses a few years of freedom. It is as if we are imprisoned. by a virus “.
Chile
